Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988;26(1):33-8.
doi: 10.1159/000293669.

Suppression of puerperal lactation by terguride. A double-blind study

P L Venturini  1 , R Horowski, V Fasce, M Valenzano, C Ferreri, G Badino, E Rainer, A Scholz, L De Cecco
Affiliations
Clinical Trial

Suppression of puerperal lactation by terguride. A double-blind study

P L Venturini et al. Gynecol Obstet Invest. 1988.

Abstract

Clinical efficacy, prolactin (PRL)-lowering effect and tolerance of terguride (an 8-alpha-ergoline derived from Lisuride which acts as a partial dopaminergic agonist) were investigated in a double-blind study on inhibition of puerperal lactation using three different daily doses of the drug (0.25, 0.5 and 1.0 mg). With 0.5 and 1.0 daily therapeutical regimens PRL levels were suppressed in a dose-dependent manner and lactation was prevented. Terguride was highly well tolerated.

PubMed Disclaimer

Publication types

LinkOut - more resources